New York Cosmetic Ingredient Bill Still In Committee With Clock Running Out

New York continues chasing California in its efforts to increase regulation of the cosmetic products sector.

Sand running through the bulbs of an hourglass measuring the passing time in a countdown to a deadline, on a dark background with copy space.

With its session winding down, the New York State Legislature is considering a bill that would require cosmetics companies to report all ingredients and nonfunctional constituents and identify those listed as chemicals of concern in a manner readily accessible to the public and machine-readable.

Under proposed A. 143 and S. 3331, manufacturers also would have to disclose “the nature and extent of investigations...

More from Legislation

More from Policy & Regulation

House Bill Aims to ‘Modernize’ US FDA’s Review Process For Sunscreens

 

Four co-chairs of the House of Representatives’ Skin Cancer Caucus have introduced the Safe Sunscreen Standards Act to direct FDA to establish clearer, ‘more flexible’ standards for evaluating sunscreen ingredients.

Beauty Industry: Counter Impact Of State Legislation By Connecting With Lawmakers – IBA

 

Beauty stakeholders will undoubtedly feel the impact of new state laws targeting cosmetic ingredients and packaging and should therefore open lines of communication with state lawmakers.

FDA’s FY 2026 Budget Request Lacks New Policy Proposals

 
• By 

The White House requested $6.8bn for the FDA, down 3.9% from the current funding level, but does not propose any legislative changes. In previous years, the agency used the budget process to seek statutory fixes specific to generic drugs and shortages.